DNA Microarray Market Growth, Growth Demand, Key Drivers, Forecast To 2033

Overview and Scope

A deoxyribonucleic acid (DNA) microarray is a powerful tool used in molecular biology to simultaneously measure the expression levels of thousands of genes. It consists of tiny spots, or probes, containing known DNA sequences immobilized on a solid surface. When a sample containing fluorescently labeled DNA is applied to the microarray, the degree of fluorescence at each spot indicates the expression level of the corresponding gene, allowing researchers to study gene expression patterns and identify biomarkers associated with various diseases or experimental conditions.

Sizing and Forecast

The DNA microarray market size has grown rapidly in recent years. It will grow from $3.02 billion in 2023 to $3.38 billion in 2024 at a compound annual growth rate (CAGR) of 12.0%.  The growth in the historic period can be attributed to pharmacogenomics, healthcare infrastructure development, collaborations and partnerships, cost reduction, and public awareness and education.

The DNA microarray market size is expected to see rapid growth in the next few years. It will grow to $5.34 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%.  The growth in the forecast period can be attributed to growth in personalized medicine, the emergence of comparative genomic hybridization (CGH), expansion in agricultural genomics, regulatory approvals, and standards, and the rising prevalence of chronic diseases. Major trends in the forecast period include advancements in genomic research, increased funding for genomic studies, technological innovations, integration with other technologies, and technological advancements.

 Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

Segmentation & Regional Insights

The DNA microarray market covered in this report is segmented –

1) By Type: Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Other Types

2) By Application: Gene Expression Analysis, Genotyping, Other Applications

3) By End-user: Pharmaceutical And Biotechnology Companies, Diagnostic Centers, Hospitals And Clinics, Academic And Research Institute, Other End-users

North America was the largest region in the DNA microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16039&type=smp

Major Driver Impacting Market Growth

The rapid adoption of personalized medicine is expected to propel the growth of the DNA microarray market. Personalized medicine tailors medical treatment to the individual characteristics of each patient, considering genetic, environmental, and lifestyle factors to optimize therapeutic efficacy and outcomes. Personalized medicine has emerged due to the rapid growth of ‘omics’ technology, data integration, genetics, and an awareness of the significance of tailored patient-specific medications and preventive actions. DNA microarrays enable personalized medicine by analyzing gene expression patterns, allowing tailored treatment plans based on an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the rapid adoption of personalized medicine is driving the DNA microarray market.

Key Industry Players

Major companies operating in the DNA microarray market are  Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

The dna microarray market report table of contents includes:

1. Executive Summary
2. DNA Microarray Market Characteristics
3. DNA Microarray Market Trends And Strategies
4. DNA Microarray Market – Macro Economic Scenario
5. Global DNA Microarray Market Size and Growth
.
32. Global DNA Microarray Market Competitive Benchmarking
33. Global DNA Microarray Market Competitive Dashboard
34. Key Mergers And Acquisitions In The DNA Microarray Market
35.DNA Microarray Market Future Outlook and Potential Analysis
36.Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

 Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model